Replying to:
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial
Arif Manji , Yvan Samson , Rebecca J. Deyell , Donna L. Johnston , Victor A. Lewis , Alexandra P. Zorzi , Jason N. Berman , Kathy Brodeur-Robb , Ellen Morrison , Lynn Kee , Sushil Kumar , Sylvain Baruchel , James A. Whitlock and Daniel A. Morgenstern from the Hospital for Sick Children, University of Toronto, the CHU Sainte-Justine, Montréal, the BC Children’s Hospital, Vancouver, the Children’s Hospital of Eastern Ontario, Ottawa, the Alberta Children’s Hospital, Calgary, the Children’s (...)
